Expansion Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Expansion Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1 (NCT03959189) | Expansion Therapeutics, Inc. | 2019-06-17 |
Track Expansion Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.